Third, available studies showed that anti-TL1A antibody significantly improved the symptoms of IBD as discussed above, however, is it feasible to be used in other ethnic populations and to treat other inflammatory autoimmune diseases? Here, TNFSF15 is linked to inflammatory bowel disease.